Dare Bioscience, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Dare Bioscience, Inc. (DARE) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $65.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-26
- Dare Bioscience, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $65.00K, a 80.71% decline from fiscal 2024.
- Dare Bioscience, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $337.00K, a 2.88% decline from fiscal 2023.
- Dare Bioscience, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $347.00K, a 18.74% decline from fiscal 2022.
- Dare Bioscience, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $427.00K, a 0.23% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month as first filed |
|---|---|---|
| 2025-12-31 | $65.00K 10-K · filed 2026-03-26 | |
| 2024-12-31 | $337.00K 10-K · filed 2026-03-26 | $237.00K 10-K · filed 2025-03-31 |
| 2023-12-31 | $347.00K 10-K · filed 2025-03-31 | |
| 2022-12-31 | $427.00K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $426.00K 10-K · filed 2023-03-30 | |
| 2020-12-31 | $237.00K 10-K · filed 2022-03-31 | |
| 2019-12-31 | $83.00K 10-K · filed 2021-03-30 | |
| 2018-12-31 | $78.00K 10-K · filed 2020-03-27 | |
| 2017-12-31 | $65.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |